DNA vaccines for transplantation

Bibliography

• Available from: www.unos.org
   Google Scholar
• Makinodan T, Santos GW, Quinn RP. Immunosuppressive drugs. Pharmacol Rev 1970;22:189-247
   PubMed Web of Science ®Google Scholar
• Cecka JM, Terasaki PI, editors, Clinical transplants. UCLA Tissue Typing Laboratory, Los Angeles, California; 1997
   Google Scholar
• Tantravahi J, Womer KL, Kaplan B. Why hasn't eliminating acute rejection improved graft survival? Annu Rev Med 2007;58:369-85
   PubMed Web of Science ®Google Scholar
• Billingham RE, Brent L, Medawar PB. ‘Actively acquired tolerance’ of foreign cells. Nature 1953;172:603-6
   PubMed Web of Science ®Google Scholar
• Monaco AP. Prospects and strategies for clinical tolerance. Transplant Proc 2004;36:227-31
   PubMed Web of Science ®Google Scholar
• Fehr T, Sykes M. Clinical experience with mixed chimerism to induce transplantation tolerance. Transpl Int 2008;21:1118-35
   PubMed Web of Science ®Google Scholar
• LeGuern C. Tolerogenic property of MHC class I and class II molecules: lessons from a gene therapy approach. Front Biosci 2007;12:3133-9
   PubMed Web of Science ®Google Scholar
• Luo B, Chan WF, Shapiro AM, Anderson CC. Non-myeloablative mixed chimerism approaches and tolerance, a split decision. Eur J Immunol 2007;37:1233-42
   PubMed Web of Science ®Google Scholar
• Vincenti F, Kirk AD. What's next in the pipeline. Am J Transplant 2008;8:1972-81
   PubMed Web of Science ®Google Scholar
• Ponce R. Adverse consequences of immunostimulation. J Immunotoxicol 2008;5:33-41
   PubMed Web of Science ®Google Scholar
• Li XC, Rothstein DM, Sayegh MH. Costimulatory pathways in transplantation: challenges and new developments. Immunol Rev 2009;229:271-93
   PubMed Web of Science ®Google Scholar
• Alegre ML, Florquin S, Goldman M. Cellular mechanisms underlying acute graft rejection: time for reassessment. Curr Opin Immunol 2007;19:563-8
   PubMed Web of Science ®Google Scholar
• Abdulhaqq SA, Weiner DB. DNA vaccines: developing new strategies to enhance immune responses. Immunol Res 2008;42:219-32
   PubMed Web of Science ®Google Scholar
• Garren H. DNA vaccines for autoimmune diseases. Expert Rev Vaccines 2009;8:1195-203
   PubMed Web of Science ®Google Scholar
• Talmage DW, Dart G, Radovich J, Lafferty KJ. Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science 1976;191:385-8
   PubMed Web of Science ®Google Scholar
• Heeger PS. T-cell allorecognition and transplant rejection: a summary and update. Am J Transplant 2003;3:525-33
   PubMed Web of Science ®Google Scholar
• Lakkis FG, Sayegh MH. Memory T cells: a hurdle to immunologic tolerance. J Am Soc Nephrol 2003;14:2402-10
   PubMed Web of Science ®Google Scholar
• Gökmen MR, Lombardi G, Lechler RI. The importance of the indirect pathway of allorecognition in clinical transplantation. Curr Opin Immunol 2008;20:568-74
   PubMed Web of Science ®Google Scholar
• Selander RK. Genetic variation in natural populations. In: Ayala FJ, editor, Molecular evolution. Sinauer Associates, Sunderland, MA; 1976. p. 21-45
   Google Scholar
• Gnudi M, Webster JP. The life and times of Gaspare Tagliacozzi, surgeon of Bologna. Reichner, Bologna and New York; 1950. p. 1545-1599
   Google Scholar
• Kuo E, Maruyama T, Fernandez F, Mohanakumar T. Molecular mechanisms of chronic rejection following transplantation. Immunol Res 2005;32:179-85
   PubMed Web of Science ®Google Scholar
• Delmas S, Picot MC, Vergnes C, Risk factors of chronic rejection in kidney transplantation, results of a single center study. Nephrologie 1999;20:153-8
   PubMedGoogle Scholar
• McDyer JF. Human and murine obliterative bronchiolitis in transplant. Proc Am Thorac Soc 2007;4:37-43
   PubMedGoogle Scholar
• Fedoseyeva EV, Tam RC, Popov IA, Induction of T cell responses to a self-antigen following allotransplantation. Transplantation 1996;61:679-83
   PubMed Web of Science ®Google Scholar
• Sumpter TL, Wilkes DS. Role of autoimmunity in organ allograft rejection: a focus on immunity to type V collagen in the pathogenesis of lung transplant rejection. Am J Physiol Lung Cell Mol Physiol 2004;286:L1129-39
   PubMed Web of Science ®Google Scholar
• Benichou G, Alessandrini A, Charrad RS, Induction of autoimmunity after allotransplantation. Front Biosci 2007;12:4362-9
   PubMed Web of Science ®Google Scholar
• Boros P, Bromberg JS. De novo autoimmunity after organ transplantation: targets and possible pathways. Hum Immunol 2008;69:383-8
   PubMed Web of Science ®Google Scholar
• Mahesh B, Leong HS, McCormack A, Autoantibodies to vimentin cause accelerated rejection of cardiac allografts. Am J Pathol 2007;170:1415-27
   PubMed Web of Science ®Google Scholar
• Fukami N, Ramachandran S, Saini D, Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection. J Immunol 2009;182:309-18
   PubMed Web of Science ®Google Scholar
• Burlingham WJ, Love RB, Jankowska-Gan E, IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007;117:3498-506
   PubMed Web of Science ®Google Scholar
• Fedoseyeva EV, Kishimoto K, Rolls HK, Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants. J Immunol 2002;169:1168-74
   PubMed Web of Science ®Google Scholar
• Yasufuku K, Heidler KM, O'Donnell PW, Oral tolerance induction by type V collagen downregulates lung allograft rejection. Am J Respir Cell Mol Biol 2001;25:26-34
   PubMed Web of Science ®Google Scholar
• Yamada Y, Sekine Y, Yoshida S, Type V collagen-induced oral tolerance plus low-dose cyclosporine prevents rejection of MHC class I and II incompatible lung allografts. J Immunol 2009;183:237-45
   PubMed Web of Science ®Google Scholar
• Lovegrove E, Pettigrew GJ, Bolton EM, Bradley JA. Epitope mapping of the indirect T cell response to allogeneic class I MHC: sequences shared by donor and recipient MHC may prime T cells that provide help for alloantibody production. J Immunol 2001;167:4338-44
   PubMed Web of Science ®Google Scholar
• Wolff JA, Malone RW, Williams P, Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465-8
   PubMed Web of Science ®Google Scholar
• Tang DC, DeVit M, Johnston SA. Genetic immunization is a simple method for eliciting an immune response. Nature 1992;356:152-4
   PubMed Web of Science ®Google Scholar
• Cui Z. DNA vaccine. Adv Genet 2005;54:257-89
   PubMed Web of Science ®Google Scholar
• Jiang S, Herrera O, Lechler RI. New spectrum of allorecognition pathways: implications for graft rejection and transplantation tolerance. Curr Opin Immunol 2004;16:550-7
   PubMed Web of Science ®Google Scholar
• Madsen JC, Superina RA, Wood KJ, Morris PJ. Immunological unresponsiveness induced by recipient cells transfected with donor MHC genes. Nature 1988;332:161-4
   PubMed Web of Science ®Google Scholar
• Geissler EK, Wang J, Fechner JH Jr, Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle. J Immunol 1994;152:413-21
   PubMed Web of Science ®Google Scholar
• Knechtle SJ, Wang J, Graeb C, Direct MHC class I complementary DNA transfer to thymus induces donor-specific unresponsiveness, which involves multiple immunologic mechanisms. J Immunol 1997;159:152-8
   PubMed Web of Science ®Google Scholar
• Yamaguchi Y, Harland RC, Wyble C, Bollinger RR. The effect of pretreatment with class I major histocompatibility complex (MHC) antigens on hepatic or cardiac allograft survival in the rat. Transplant Proc 1989;21:3555
   PubMed Web of Science ®Google Scholar
• Spriewald BM, Ensminger SM, Jenkins S, Intrathymic delivery of plasmid-encoding endoplasmic reticulum signal-sequence-deleted MHC class I alloantigen can induce long-term allograft survival. Transpl Int 2004;17:458-62
   PubMed Web of Science ®Google Scholar
• Zhai Y, Hong X, Wang J, Modulation of alloimmunity to major histocompatibility complex class I by cotransfer of cytokine genes in vivo. Transpl Immunol 1998;6:169-75
   PubMed Web of Science ®Google Scholar
• Pettigrew GJ, Lovegrove E, Bradley JA, Indirect T cell allorecognition and alloantibody-mediated rejection of MHC class I-disparate heart grafts. J Immunol 1998;161:1292-8
   PubMed Web of Science ®Google Scholar
• Pêche H, van Denderen B, Roussel JC, Presentation of donor major histocompatibility complex class II antigens by DNA vaccination prolongs heart allograft survival. Transplantation 2004;77:733-40
   PubMed Web of Science ®Google Scholar
• Doenecke A, Frank E, Scherer MN, Prolongation of heart allograft survival after long-term expression of soluble MHC class I antigens and vIL-10 in the liver by AAV-plasmid-mediated gene transfer. Langenbecks Arch Surg 2008;393:343-8
   PubMed Web of Science ®Google Scholar
• Vignes C, Chiffoleau E, Brouard S, Anti-TCR Vbeta-specific DNA vaccination prolongs heart allograft survival in adult rats. Eur J Immunol 2000;30:2460-4
   PubMed Web of Science ®Google Scholar
• Seifarth C, Pop S, Liu B, More stringent conditions of plasmid DNA vaccination are required to protect grafted versus endogenous islets in nonobese diabetic mice. J Immunol 2003;171:469-76
   PubMed Web of Science ®Google Scholar
• Neu N, Rose NR, Beisel KW, Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 1987;139:3630-6
   PubMed Web of Science ®Google Scholar
• Fedoseyeva EV, Zhang F, Orr PL, De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 1999;162:6836-42
   PubMed Web of Science ®Google Scholar
• Li A, Chen J, Hattori M, A therapeutic DNA vaccination strategy for autoimmunity and transplantation. Vaccine 2010;28:1897-904
   Google Scholar
• Valujskikh A, Fedoseyeva E, Benichou G, Development of autoimmunity after skin graft rejection via an indirect alloresponse. Transplantation 2002;73:1130-7
   PubMed Web of Science ®Google Scholar
• Williams MA, Trambley J, Ha J, Genetic characterization of strain differences in the ability to mediate CD40/CD28-independent rejection of skin allografts. J Immunol 2000;165:6849-57
   PubMed Web of Science ®Google Scholar
• Kono T, Nishimura F, Sugimoto H, Human fibroblasts ubiquitously express glutamic acid decarboxylase 65 (GAD 65): possible effects of connective tissue inflammation on GAD antibody titer. J Periodontol 2001;72:598-604
   PubMed Web of Science ®Google Scholar
• Ito K, Tanaka K, Nishibe Y, GABA-synthesizing enzyme, GAD67, from dermal fibroblasts: evidence for a new skin function. Biochim Biophys Acta 2007;1770:291-6
   Google Scholar
• Yu S, He X, Hu A, Rapamycin combined with donor bone marrow-derived immature dendritic cells induces mouse skin allograft tolerance. Nan Fang Yi Ke Da Xue Xue Bao 2008;28:399-402
   PubMedGoogle Scholar
• Rothstein DM, Livak MF, Kishimoto K, Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models. J Immunol 2001;166:322-9
   PubMed Web of Science ®Google Scholar
• Sho M, Kishimoto K, Harada H, Requirements for induction and maintenance of peripheral tolerance in stringent allograft models. Proc Natl Acad Sci USA 2005;102:13230-5
   PubMed Web of Science ®Google Scholar
• Chowdhury NC, Murphy B, Sayegh MH, Acquired systemic tolerance to rat cardiac allografts induced by intrathymic inoculation of synthetic polymorphic MHC class I allopeptides. Transplantation 1996;62:1878-82
   PubMed Web of Science ®Google Scholar
• Bittencourt MC, Perruche S, Contassot E, Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers. Blood 2001;98:224-30
   PubMed Web of Science ®Google Scholar
• Kaneko K, Morelli AE, Wang Z, Thomson AW. Alloantigen presentation by ethylcarbodiimide-treated dendritic cells induces T cell hyporesponsiveness, and prolongs organ graft survival. Clin Immunol 2003;108:190-8
   PubMed Web of Science ®Google Scholar
• Wang Z, Shufesky WJ, Montecalvo A, In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy. PLoS One 2009;4:e4940
   PubMedGoogle Scholar
• Barr ML, Meiser BM, Eisen HJ, Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group. N Engl J Med 1998;339:1744-51
   PubMed Web of Science ®Google Scholar
• Kirklin JK, Brown RN, Huang ST, Rejection with hemodynamic compromise: objective evidence for efficacy of photopheresis. J Heart Lung Transplant 2006;25:283-8
   PubMed Web of Science ®Google Scholar
• Lamioni A, Carsetti R, Legato A, Induction of regulatory T cells after prophylactic treatment with photopheresis in renal transplant recipients. Transplantation 2007;83:1393-6
   PubMed Web of Science ®Google Scholar
• Skoberne M, Beignon AS, Larsson M, Bhardwaj N. Apoptotic cells at the crossroads of tolerance and immunity. Curr Top Microbiol Immunol 2005;289:259-92
   PubMed Web of Science ®Google Scholar
• Giannoukakis N, Thomson A, Robbins P. Gene therapy in transplantation. Gene Ther 1999;6:1499-511
   PubMed Web of Science ®Google Scholar
• Li XK, Okuyama T, Tamura A, Prolonged survival of rat liver allografts transfected with Fas ligand-expressing plasmid. Transplantation 1998;66:1416-23
   PubMed Web of Science ®Google Scholar
• Wang Y, Gao Y, Yuan X, The liver mediates apoptotic cell-induced immune regulation. Scand J Immunol 2008;68:297-305
   PubMed Web of Science ®Google Scholar
• Isaacs JD. T cell immunomodulation – the Holy Grail of therapeutic tolerance. Curr Opin Pharmacol 2007;7:418-25
   PubMed Web of Science ®Google Scholar
• Boros P, Bromberg JS. Human FOXP3+ regulatory T cells in transplantation. Am J Transplant 2009;9:1719-24
   PubMed Web of Science ®Google Scholar
• Silk KM, Fairchild PJ. Harnessing dendritic cells for the induction of transplantation tolerance. Curr Opin Organ Transplant 2009;14:344-50
   PubMed Web of Science ®Google Scholar
• Scherer MN, Graeb C, Tange S, Immunologic considerations for therapeutic strategies utilizing allogeneic hepatocytes: hepatocyte-expressed membrane-bound major histocompatibility complex class I antigen sensitizes while soluble antigen suppresses the immune response in rats. Hepatology 2000;32:999-1007
   PubMed Web of Science ®Google Scholar
• Graeb C, Justl M, Scherer MN, Expression of high levels of soluble allogeneic major histocompatibility complex class I antigen by adenoviral gene transfer strongly inhibits allospecific cytotoxic T lymphocytes in vivo. Transplant Proc 2002;34:1398-9
   PubMed Web of Science ®Google Scholar
• Gagne K, Brouard S, Guillet M, TGF-beta1 and donor dendritic cells are common key components in donor-specific blood transfusion and anti-class II heart graft enhancement, whereas tolerance induction also required inflammatory cytokines down-regulation. Eur J Immunol 2001;31:3111-20
   PubMed Web of Science ®Google Scholar
• Vignes C, Chiffoleau E, Douillard P, Anti-TCR-specific DNA vaccination demonstrates a role for a CD8+ T cell clone in the induction of allograft tolerance by donor-specific blood transfusion. J Immunol 2000;165:96-101
   PubMed Web of Science ®Google Scholar
• Jurcevic S, Ainsworth ME, Pomerance A, Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 2001;71:886-92
   PubMed Web of Science ®Google Scholar
• Iwata T, Philipovskiy A, Fisher AJ, Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction. J Immunol 2008;181:5738-47
   PubMed Web of Science ®Google Scholar
• Jiang H, Chess L. How the immune system achieves self-nonself discrimination during adaptive immunity. Adv Immunol 2009;102:95-133
   PubMed Web of Science ®Google Scholar
• Li AF, Hough J, Henderson D, Escher A. Co-delivery of pro-apoptotic BAX with a DNA vaccine recruits dendritic cells and promotes efficacy of autoimmune diabetes prevention in mice. Vaccine 2004;22:1751-63
   PubMed Web of Science ®Google Scholar
• Li A, Ojogho O, Franco E, Pro-apoptotic DNA vaccination ameliorates new onset of autoimmune diabetes in NOD mice and induces foxp3+ regulatory T cells in vitro. Vaccine 2006;24:5036-46
   PubMed Web of Science ®Google Scholar
• Kawai T, Cosimi AB, Spitzer TR, HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008;358:353-61
   PubMed Web of Science ®Google Scholar